ImmunoGen, Inc. (IMGN) Announces Webcast of Presentations at Upcoming Investor Conferences  
11/6/2012 7:46:47 AM

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

Lazard Capital Markets 9th Annual Healthcare Conference

3:00 pm ET on November 14, 2012 in New York, NY

Presenter: Gregory Perry, Executive Vice President and CFO